Revenue Summary of Formosa Laboratories, Inc.

Formosa Laboratories, Inc.'s latest annual revenue in 2023 was 4.36 Billion TWD , up 15.8% from previous year.
Formosa Laboratories, Inc.'s latest quarterly revenue in 2024 Q2 was 1.21 Billion TWD , up 7.09% from previous quarter.
Formosa Laboratories, Inc. reported a annual revenue of 3.76 Billion TWD in annual revenue 2022, up 19.83% from previous year.
Formosa Laboratories, Inc. reported a annual revenue of 3.14 Billion TWD in annual revenue 2021, up 2.18% from previous year.
Formosa Laboratories, Inc. reported a quarterly revenue of 1.21 Billion TWD for 2024 Q2, up 7.09% from previous quarter.
Formosa Laboratories, Inc. reported a quarterly revenue of 4.36 Billion TWD for 2023 FY, up 15.8% from previous quarter.

Annual Revenue Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual Revenue of Formosa Laboratories, Inc. (2023 - 2009)

Year	Revenue	Revenue Growth
2023	4.36 Billion TWD	15.8%
2022	3.76 Billion TWD	19.83%
2021	3.14 Billion TWD	2.18%
2020	3.07 Billion TWD	11.45%
2019	2.75 Billion TWD	2.67%
2018	2.68 Billion TWD	5.84%
2017	2.53 Billion TWD	-20.38%
2016	3.18 Billion TWD	22.82%
2015	2.59 Billion TWD	4.03%
2014	2.49 Billion TWD	0.91%
2013	2.47 Billion TWD	-2.01%
2012	2.52 Billion TWD	-3.86%
2011	2.62 Billion TWD	4.78%
2010	2.5 Billion TWD	0.0%
2009	- TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	1.13 Billion TWD	-6.45%
2024 Q2	1.21 Billion TWD	7.09%
2023 FY	4.36 Billion TWD	15.8%
2023 Q4	1.21 Billion TWD	7.36%
2023 Q3	1.12 Billion TWD	3.89%
2023 Q2	1.08 Billion TWD	16.63%
2023 Q1	931.96 Million TWD	-12.76%
2022 Q3	1.02 Billion TWD	22.17%
2022 Q1	834.94 Million TWD	-6.09%
2022 FY	3.76 Billion TWD	19.83%
2022 Q4	1.06 Billion TWD	4.32%
2022 Q2	838.21 Million TWD	0.39%
2021 Q3	689.67 Million TWD	-16.64%
2021 Q2	827.34 Million TWD	12.37%
2021 FY	3.14 Billion TWD	2.18%
2021 Q1	736.27 Million TWD	-9.14%
2021 Q4	889.11 Million TWD	28.92%
2020 Q2	787.7 Million TWD	18.87%
2020 Q3	814.72 Million TWD	3.43%
2020 FY	3.07 Billion TWD	11.45%
2020 Q1	662.64 Million TWD	-8.18%
2020 Q4	810.38 Million TWD	-0.53%
2019 Q2	594.04 Million TWD	-9.21%
2019 Q1	654.32 Million TWD	-6.14%
2019 Q4	721.64 Million TWD	-8.6%
2019 Q3	789.58 Million TWD	32.92%
2019 FY	2.75 Billion TWD	2.67%
2018 Q1	612.61 Million TWD	-8.34%
2018 Q3	684.92 Million TWD	-1.18%
2018 Q4	697.12 Million TWD	1.78%
2018 FY	2.68 Billion TWD	5.84%
2018 Q2	693.07 Million TWD	13.13%
2017 Q3	626.31 Million TWD	-6.23%
2017 Q2	667.9 Million TWD	15.81%
2017 Q1	576.74 Million TWD	-26.08%
2017 FY	2.53 Billion TWD	-20.38%
2017 Q4	668.37 Million TWD	6.72%
2016 Q2	897.05 Million TWD	20.56%
2016 FY	3.18 Billion TWD	22.82%
2016 Q3	768.05 Million TWD	-14.38%
2016 Q1	744.04 Million TWD	-14.54%
2016 Q4	780.23 Million TWD	1.59%
2015 Q4	870.6 Million TWD	22.12%
2015 Q2	485.08 Million TWD	-8.15%
2015 Q1	528.13 Million TWD	0.49%
2015 Q3	712.9 Million TWD	46.97%
2015 FY	2.59 Billion TWD	4.03%
2014 Q1	608.78 Million TWD	-17.66%
2014 FY	2.49 Billion TWD	0.91%
2014 Q4	525.54 Million TWD	-8.75%
2014 Q3	575.94 Million TWD	-26.72%
2014 Q2	785.95 Million TWD	29.1%
2013 Q4	739.33 Million TWD	2.96%
2013 Q1	237.69 Million TWD	-60.02%
2013 Q2	778.55 Million TWD	227.54%
2013 FY	2.47 Billion TWD	-2.01%
2013 Q3	718.05 Million TWD	-7.77%
2012 Q2	629.47 Million TWD	-0.36%
2012 Q1	631.73 Million TWD	-11.51%
2012 Q3	668.59 Million TWD	6.21%
2012 Q4	594.47 Million TWD	-11.08%
2012 FY	2.52 Billion TWD	-3.86%
2011 Q1	602.45 Million TWD	-75.96%
2011 Q4	713.86 Million TWD	-1.47%
2011 Q2	584.77 Million TWD	-2.93%
2011 Q3	724.54 Million TWD	23.9%
2011 FY	2.62 Billion TWD	4.78%
2010 Q4	2.5 Billion TWD	0.0%
2010 Q1	- TWD	0.0%
2010 Q2	- TWD	0.0%
2010 FY	2.5 Billion TWD	0.0%
2010 Q3	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Revenue Comparison of Formosa Laboratories, Inc.

Name	Revenue	Revenue Difference
Grape King Bio Ltd	10.63 Billion TWD	58.991%
Standard Chem & Pharm CO., LTD.	6.23 Billion TWD	30.118%
Maywufa Company Ltd.	1.3 Billion TWD	-235.233%
ScinoPharm Taiwan, Ltd.	3.18 Billion TWD	-36.859%
Lotus Pharmaceutical Co., Ltd.	16.95 Billion TWD	74.287%
LIWANLI Innovation Co., Ltd.	38.88 Million TWD	-11113.125%
YungShin Global Holding Corporation	7.02 Billion TWD	37.956%
PhytoHealth Corporation	162.48 Million TWD	-2583.534%
SCI Pharmtech, Inc.	1.2 Billion TWD	-262.116%
PharmaEssentia Corporation	5.1 Billion TWD	14.595%
Bora Pharmaceuticals Co., LTD.	14.2 Billion TWD	69.293%

Global Stocks Search

Formosa Laboratories, Inc. (4746.TW)

Revenue Summary of Formosa Laboratories, Inc.

Annual Revenue Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual Revenue of Formosa Laboratories, Inc. (2023 - 2009)

Peer Revenue Comparison of Formosa Laboratories, Inc.